[EN] QUINOLINYL GLUCAGON RECEPTOR MODULATORS<br/>[FR] MODULATEURS DES RÉCEPTEURS DE QUINOLINYLGLUCAGON
申请人:PFIZER
公开号:WO2013014569A1
公开(公告)日:2013-01-31
The present invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, A1, A2, A3, B1, B2, B3 and B4 are as defined herein. The compounds of Formula I have been found to act as glucagon antagonists or inverse agonists. Consequently, the compounds of Formula I and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucagon.
本发明提供了一种式I的化合物或其药用可接受的盐,其中R1、R2、R3、A1、A2、A3、B1、B2、B3和B4如本文所定义。已发现式I的化合物可作为胰高血糖素拮抗剂或逆拮抗剂。因此,式I的化合物及其药物组成物对于治疗由胰高血糖素介导的疾病、紊乱或症状是有用的。